Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age50-80
SponsorEvergreen General Hospital, Taiwan
About this trial
This is a prospective equivalence colonoscopy study evaluating whether overall adenoma detection rate (ADR) is a reliable alternate for screening ADR. Overall indication includes screening, surveillance, and diagnostic indications.
Eligibility criteria
Qualifiers
consecutive patients aged ≥50 years undergoing colonoscopy are eligible for enrollment.
Disqualifiers
high risk family history of colorectal cancer (CRC) e.g., familial adenomatous polyposis, hereditary non-polyposis CRC syndrome, multiple first degree relatives with CRC, or a single first degree relative with CRC at <60 years
serrated polyposis syndrome
inflammatory bowel disease
colonoscopy to remove a large neoplastic polyps
Trial design
Treatments tested in this trial
- Comparison of ADR
Treatment groups
2,700 Participants
are divided into 4 treatment groupsSponsors and collaborators
Evergreen General Hospital, Taiwan
Lead sponsor
E-DA Hospital
Collaborator
E-Da Dachang Hospital
Collaborator
Chang Gung Memorial Hospital
Collaborator
Sepulveda Ambulatory Care Center, Veterans Affairs Greater Los Angeles Healthcare System
Collaborator
Source ClinicalTrials.gov